The dissociation between the diabetes and both Child-Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic

Hepatology International

Volumn 5, Issue 4, 2011, Pages 955-964

  Chen, Yu Wei ^a,b   Chen, Han Hsiang ^a,b,c   Wang, Tsang En ^a,b   Chang, Ching Wei ^a,b   Chang, Chen Wang ^a,b   Chen, Wei Che ^a,b   Wu, Chih Jen ^a,b,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Child Pugh score; Diabetes mellitus; Hepatitis B virus; Liver cirrhosis; MELD score

Indexed keywords

CREATININE;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

EID: 85027958367     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9274-y     Document Type: Article

References (29)

1. D Garcia-Compean JO Jaquez-Quintana JA Gonzalez-Gonzalez, et al. 2009 Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management World J Gastroenterol 15 3 280 288 19140227 10.3748/wjg.15.280 1:CAS:528:DC%2BD1MXisVSmsLg%3D
2. C Postic R Dentin J Girard 2004 Role of the liver in the control of carbohydrate and lipid homeostasis Diabetes Metab 30 5 398 408 15671906 10.1016/S1262-3636(07)70133-7 1:CAS:528:DC%2BD2MXlsFeitbc%3D (Pubitemid 39648006)
3. KG Tolman V Fonseca A Dalpiaz, et al. 2007 Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease Diabetes Care 30 3 734 743 17327353 10.2337/dc06-1539 1:CAS:528: DC%2BD2sXjs1Grurk%3D (Pubitemid 46354365)
4. C Megyesi E Samols V Marks 1967 Glucose tolerance and diabetes in chronic liver disease Lancet 2 7525 1051 1056 4168535 10.1016/S0140-6736(67)90334-0 1:STN:280:DyaF1c%2Flt1ahtg%3D%3D
5. G Perseghin V Mazzaferro LP Sereni, et al. 2000 Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation Hepatol 31 3 694 703 10.1002/hep.510310320 1:CAS:528:DC%2BD3cXhvFGjsrk%3D (Pubitemid 30118638)
6. T Kawaguchi T Yoshida M Harada, et al. 2004 Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 Am J Pathol 165 5 1499 1508 15509521 10.1016/S0002-9440(10)63408-6 1:CAS:528:DC%2BD2cXhtVCgsLfI (Pubitemid 39435150)
7. D García-Compean JO Jaquez-Quintana H Maldonado-Garza 2009 Hepatogenous diabetes. Current views of an ancient problem Ann Hepatol 8 1 13 20 19221528
8. JN Wei LM Chuang RS Lin, et al. 2002 Prevalence and hospitalization rates of diabetes mellitus in Taiwan, 1996-2000 Taiwan J Public Health 21 3 173 180
9. National Diabetes Data Group 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group Diabetes 28 12 1039 1057
10. American Diabetes Association 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 Suppl 1 S5 S20
11. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 S1 S266
12. US Department of Health and Human Services 1997 Trends in the prevalence and prevalence of self-reported diabetes mellitus-United States, 1980-1994 MMWR Morb Mortal Wkly Rep 46 1014 1018
13. GM Reaven 1995 Pathophysiology of insulin resistance in human disease Physiol Rev 75 3 473 486 7624391 1:STN:280:DyaK2MzltVagtw%3D%3D
14. H Knobler R Schihmanter A Zifroni, et al. 2000 Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection Mayo Clin Proc 75 4 355 359 10761489 10.4065/75.4.355 1:STN:280: DC%2BD3c3isVGmtw%3D%3D (Pubitemid 30187108)
15. GM Fraser I Harman N Meller, et al. 1996 Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection Isr J Med Sci 32 7 526 530 8756978 1:STN:280:DyaK28zkvVShsQ%3D%3D (Pubitemid 26280438)
16. GV Papatheodoridis N Chrysanthos S Savvas, et al. 2006 Diabetes mellitus in chronic hepatitis B and C: Prevalence and potential association with the extent of liver fibrosis J Viral Hepatol 13 5 303 310 10.1111/j.1365-2893.2005. 00677.x 1:STN:280:DC%2BD283jt1SjsQ%3D%3D
17. M Deschenes KA Somberg 1998 Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus Am J Gastroenterol 93 3 483 9517672 10.1111/j.1572-0241.1998. 481-4.x 1:STN:280:DyaK1c7ns1ymsw%3D%3D (Pubitemid 29068368)
18. NN Zein AS Abdulkarim RH Wiesner, et al. 2000 Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease J Hepatol 32 2 209 217 10707860 10.1016/S0168-8278(00) 80065-3 1:STN:280:DC%2BD3c7ntVWgsQ%3D%3D (Pubitemid 30093899)
19. YW Chen CJ Wu CW Chang, et al. 2011 Renal Function in Patients with Liver Cirrhosis Nephron Clin Pract 118 2 195 203 10.1159/000321384
20. LA Adams S Sanderson KD Lindor, et al. 2005 The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies J Hepatol 42 1 132 138 15629518 10.1016/j.jhep.2004. 09.012 (Pubitemid 40038911)
21. N Taura T Ichikawa K Hamasaki, et al. 2006 Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients Am J Gastroenterol 101 12 2752 2759 17026566 10.1111/j.1572-0241.2006.00835.x 1:CAS:528:DC%2BD2sXht1aqtL0%3D (Pubitemid 44902647)
22. RH Wiesner SV McDiarmid PS Kamath, et al. 2001 MELD and PELD: Application of survival models to liver allocation Liver Transpl 7 7 567 580 11460223 10.1053/jlts.2001.25879 1:STN:280:DC%2BD3MvhtFyntA%3D%3D (Pubitemid 32677880)
23. A Holstein S Hinze E Thiessen, et al. 2002 Clinical implications of hepatogenous diabetes in liver cirrhosis J Gastroenterol Hepatol 17 6 677 681 12100613 10.1046/j.1440-1746.2002.02755.x (Pubitemid 34748159)
24. YW Chen CJ Wu TE Wang, et al. 2010 The mortality survey of elderly cirrhotic patients in Taiwan-a single center experience J Am Geriatr Soc 58 11 2230 2232 21054306 10.1111/j.1532-5415.2010.03102.x
25. M Trombetta G Spiazzi G Zoppini, et al. 2005 Review article: Type 2 diabetes and chronic liver disease in the Verona diabetes study Aliment Pharmacol Ther 22 Suppl. 2 24 27 16225467 10.1111/j.1365-2036.2005.02590.x (Pubitemid 41564377)
26. G Bianchi G Marchesini M Zoli, et al. 1994 Prognostic significance of diabetes in patients with cirrhosis Hepatol 20 1 119 125 1:STN:280: DyaK2c3pt1SqtQ%3D%3D (Pubitemid 24196500)
27. JM Yuan S Govindarajan K Arakawa, et al. 2004 Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S Cancer 101 5 1009 1017 15329910 10.1002/cncr.20427 (Pubitemid 39100435)
28. T Kawaguchi E Taniguchi Y Morita, et al. 2010 Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection Liver Int 30 3 479 486 20040053 10.1111/j.1478-3231.2009.02191.x 1:CAS:528:DC%2BC3cXis1Wku7Y%3D
29. V Donadon M Balbi M Ghersetti, et al. 2009 Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease World J Gastroenterol 15 20 2506 2511 19469001 10.3748/wjg.15.2506 1:CAS:528: DC%2BD1MXpsF2rtrs%3D